Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC219

Brodalumab

  • Status:
    Veitt
  • Application date:
    16.1.2018
  • Application published:
    15.2.2018
  • Grant published:
    15.9.2021
  • Max expiry date:
    18.7.2032
  • Medicine name:
    Kyntheum
  • Medicine for children:
    No

Timeline

Today
16.1.2018Application
15.2.2018Publication
15.9.2021Registration
18.7.2032Expires

Marketing license

  • IS authorization number:
    EU/1/16/1155/001
  • Date:
    16.8.2017
  • Foreign authorization number:
    EU/1/16/1155
  • Date:
    17.7.2017

Owner

  • Name:
    Kirin-Amgen, Inc.
  • Address:
    One Amgen Center Drive, Thousand Oaks US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents